No significant between-cohort differences were found in these intermediate outcomes, albeit a possible trend was observed for more patients with early-stage disease in the intervention arm, as indicated by the ratio of stage I+II / stage IV cases (14.7% / 35% = 0.42 in the intervention cohort; 11.8% / 41.1% = 0.29 in the control cohort).
← all excerpts
Improved survival of non-small cell lung cancer patients after introducing patient navigation: A retrospective cohort study with propensity score weighted historic control.
1
—
—